Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis

INTRODUCTION: Within 30 years, 20–50% of IgA nephropathy (IgAN) patients progress to end-stage kidney disease (ESKD). Identifying these patients can be difficult since renal function may deteriorate after being stable for years. The International IgAN Risk Prediction tool (IgAN-RPT) combines histolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebbestad, Robin, Sanaei Nurmi, Mazdak, Lundberg, Sigrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Clinical Practice: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808712/
https://www.ncbi.nlm.nih.gov/pubmed/35671707
http://dx.doi.org/10.1159/000525001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808712/
https://www.ncbi.nlm.nih.gov/pubmed/35671707
http://dx.doi.org/10.1159/000525001

Ejemplares similares